FDA Investigator Melba Trivera Clavell

Melba Trivera Clavell has inspections in 7 countries as of 16 Nov 2023. Melba Trivera Clavell has collaborated with a combinined 2927 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
44
Last Inspection Date:
16 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
100003933
Country:
United States of America, Germany, Argentina, Switzerland, United Kingdom of Great Britain and Northern Ireland, Brazil, Italy
Co-Investigator(s):
Alberto A Viciedo, Allen Lou, Amatul H Marium, Amy L Singer, Amy M Cramer, Ana S Cabrera, Anastasia M Shields, Andrew J Molesky, Ann Marie Montemurro, Annemarie B Randow, Annemarie Bodnar, Annet R Rajan, Anthony J Donato, Anthony R Rauert, Azza Talaat, Barbara J Maulfair, Barbara J Wilimczyk, Barbara Jwilimczyk Macri, Barbara L Rellahan, PhD, Blondell W Johnson, Brandi L Garbutt, Bruce H Mccullough, Cara M Minelli, Carl A Perez, Cary Greene, Charles J Chacko, Charles M Edwards, Craig W Swanson, Cynthia J Lee, MS, Cynthia M Goudeau, Daniel J Grabicki, David H Smith, Deborah B Goffman, Deborah B Nixon, Dhaval H Patel, Douglas C Kovace, Douglas C Kovacs, Dr. Barbara D Paul, PhD, Dr. Zhou Chen (nmi), MD PhD, Eileen A Liu, Elizabeth D Connell, Emest F Bizjak, Emmanuel J Ramos, Eric J Cunningham, Eric Rothschild, Erin D Mccaffery, Felix Maldonado, Frank J Marciniak, George M Ibrahim, Gianine E Delade, Gianine E Thompkins, Gianine E Tompkins, Guerlain Ulysse, Gwyn G Dickinson, Helen B Ricalde, Helen Verdel, Herrmann, Jacqueline Mdiaz Albertini, James C Maclaughlin, Jason M Sluzynski, Jean M Kelahan, Jessica L Pressley, Jocelyn C Turner, Jogy George, John A Podsadowski, Jonee J Mearns, Jose E Melendez, DDC, Jose M Cayuela, Jose V Obando, Joseph F Mcginnis, RPh, Joy R Kelna, Joy Rkozlowski Klena, Julie D Bringger, Karen E D'orazio, Kazi Rafiquzzaman, Keith M Reilly, Kelli F Dobilas, Kelly Doremus, Kenneth M Gordon, Kent C Faul, Kevin Obrien, Kham Phommachanh, Kimberly Lewandowski Walker, King, Kinh Q Mac, Kinh Qouc Mac, Kristy A Zielny, Krystal O Ogunremi, Kyle D Covill, Lata C Mathew, PhD, Lawrence R Johnson, Leticia S Jones, Li Li, Liatte Kreuger, PharmD, Lisa B Hall, Lisa Harlan, Luis M Burgos Medero, Malik S Qaiser, Marie F Morin, Marjorie D Schultz, Mark E Parmon, Matthew A Spataro, Matthew Sparato, Melba T Rivera, Melissa A Zuppe, Melissa B Libby, Melissa T Roy, Meyer J Slobotsky, Michael J Kuchta, Michael R Klapal, Michael Serrano, Michele Gottshall, Michele L Obert, Miguel G Manzano, Nancy F Scheraga, Nancy L Rolli, Niketa Patel, Nikki S Ramirez, Niraj Mehta, Paraluman S Leonin, Parul M Patel, Paul L Bellamy, Peter R Lenahan, Prabhu P Raju, Rebecca Rodriguez, Regina T Brown, Remache, Richard D Manney, Robert G Ruff, Robert J Martin, Russell J Glapion, Saied A Asbagh, Samantha J Bradley, Sandra Kershaw, Sarah Adella Fave, Schultz, Shawn R Gould, Sherri J Liu, Sherry G Bous, Shirley H Isbill, Sidney B Priesmeyer, Sinai Davis, State Agency, Stephen J Mottola, Susan M Halsted, Susant Hadman, Tamil Arasu, PhD, Tania E Vizcaino, Tara G Bizjak, Tara R Gooen, Thomas J Arista, Thomas M Herbst, Tiffani D Wilson, Tomika L Bivens, Tonia F Bernard, Tressa T Lewis, Ucheabuchi C Chudi Nwankwor, Unnee Ranjan, Valerie C Reed, Valerie Reed, Victoria Spivak, Vlada Matusovsky, Walden H Lee, Wayne J Meyer, Wei Wang, PhD, Xiuju Lu, Yasamin Ameri, Yvesna C Blaise, Zachary L Miller, Zakaria I Ganiyu

Melba Trivera Clavell's Documents

Publish Date Document Type Title
July, 2012 EIR DAVA Pharmaceuticals, Inc. - EIR, 2012-07-06
December, 2010 FDA 483 Genzyme Corporation - Form 483, 2010-12-21
March, 2013 EIR Micra Biotechnologies Inc - EIR, 2013-03-04
November, 2012 FDA 483 Sourcetech Quimica Ltda - Form 483, 2012-11-30
August, 2013 EIR Vitaquest International LLC d/b/a State Nutritionals, Inc. - EIR, 2013-08-28
September, 2012 FDA 483 James Alexander Corporation - Form 483, 2012-09-10
February, 2011 FDA 483 Hoffmann La Roche Inc - Form 483, 2011-02-04
February, 2013 FDA 483 Ameriderm Laboratories, Ltd. - Form 483, 2013-02-13
July, 2012 FDA 483 DAVA Pharmaceuticals, Inc. - Form 483, 2012-07-17
February, 2012 FDA 483 Biogenesis Inc. - Form 483, 2012-02-02
November, 2010 EIR Queseria Chipilo, Inc. - EIR, 2010-11-08
March, 2011 FDA 483 June Jacobs Labs, LLC - Form 483, 2011-03-21
August, 2011 FDA 483 Promeko, Inc. - Form 483, 2011-08-30
May, 2012 FDA 483 Organics Corporation of America DBA Ambix Laboratories - Form 483, 2012-05-07
March, 2013 FDA 483 Micra Biotechnologies Inc - Form 483, 2013-03-04

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more